AbCellera Completes Antibody Discovery Project With Kodiak Sciences to Identify Lead Therapeutic Candidates VANCOUVER, British Columbia, Aug. 24, 2016 (GLOBE NEWSWIRE) -- AbCellera Biologics Inc., a biotechnology company specializing in the rapid discovery of monoclonal antibodies from natural immune...